U.S. Covid-19 Vaccine Supply Is Poised to Double

The U.S. vaccine supply is about to get a whole lot bigger.

Currently, the U.S. is administering 1.6 million doses a day, constrained by the current supply of about 10 million to 15 million doses a week. But manufacturers and U.S. officials have accelerated their production timelines and signaled that the spigots are about to open. That will provide hundreds of millions of doses to match the growing capacity to immunize people at pharmacies and mass-vaccination sites.

“What we are going to see is every week a continued ramp,” says Andy Slavitt, White House senior adviser for Covid response. By the end of March, he says, there should be 200 million doses available for distribution to states — about 90 million more than the current total, according to U.S. figures.

A review of drugmakers’ public statements and their supply deals suggests that the number of vaccines delivered should rise to almost 20 million a week in March, more than 25 million a week in April and May, and over 30 million a week June. By summer, it would be enough to give 4.5 million shots a day.

Subscribe to our YouTube channel

Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.

To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.

Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake

Connect with us on…

Breaking News on YouTube